|Bid||2.4460 x N/A|
|Ask||2.4740 x N/A|
|Day's Range||2.3740 - 2.3740|
|52 Week Range||0.9675 - 2.5760|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
With the business potentially at an important milestone, we thought we'd take a closer look at Verastem, Inc.'s...
Verastem, Inc. (Nasdaq: VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today reported financial results for the three months ended March 31, 2021, highlighted recent progress and outlined key corporate objectives.
A look at the shareholders of Verastem, Inc. ( NASDAQ:VSTM ) can tell us which group is most powerful. Institutions...